Blog
About

0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Daclatasvir plus asunaprevir (DCV + ASV) has demonstrated potent antiviral activity in patients with hepatitis C virus (HCV) genotype 1b (GT-1b) infection in the HALLMARK DUAL trial. This post hoc analysis was conducted to determine the efficacy and safety of this treatment in Asian patients.

          Related collections

          Author and article information

          Journal
          Liver Int.
          Liver international : official journal of the International Association for the Study of the Liver
          Wiley-Blackwell
          1478-3231
          1478-3223
          Oct 2016
          : 36
          : 10
          Affiliations
          [1 ] Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan. kaojh@ntu.edu.tw.
          [2 ] Department of Internal Medicine, Inje University Busan-Paik Hospital, Busan, Republic of Korea.
          [3 ] Department of Internal Medicine, Pusan National University, Busan, Republic of Korea.
          [4 ] Department of Internal Medicine, Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Republic of Korea.
          [5 ] Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
          [6 ] China Medical University, School of Medicine, Taichung, Taiwan.
          [7 ] Department of Internal Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
          [8 ] Global Biometric Sciences, Bristol-Myers Squibb, Braine-l'Alleud, Belgium.
          [9 ] Research and Development, Bristol-Myers Squibb, Princeton, NJ, USA.
          Article
          10.1111/liv.13128
          27009831

          daclatasvir, Asia, genotype 1b, asunaprevir

          Comments

          Comment on this article